Immunogen, Inc. (NASDAQ: IMGN) Q1 2021 earnings name dated Might. 10, 2021 Presentation: Operator Good morning, and welcome to the ImmunoGen’s First Quarter of 2020 Monetary and Working Outcomes Convention…
This transcript is produced by AlphaStreet, Inc. Whereas we attempt to provide the very best transcripts, it might comprise misspellings and different inaccuracies. This transcript is supplied as is with out specific or implied warranties of any sort. As with all our articles, AlphaStreet, Inc. doesn’t assume any accountability in your use of this content material, and we strongly encourage you to do your individual analysis, together with listening to the decision your self and studying the corporate’s SEC filings. Neither the knowledge nor any opinion expressed on this transcript constitutes a solicitation of the acquisition or sale of securities or commodities. Any opinion expressed within the transcript doesn’t essentially replicate the views of AlphaStreet, Inc.
© COPYRIGHT 2021, AlphaStreet, Inc. All rights reserved. Any copy, redistribution or retransmission is expressly prohibited.